A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2009
12/23/2009	EP1107782B1 Oral vaccine compositions
12/23/2009	EP1094837B1 Porcine circovirus and parvovirus vaccine
12/23/2009	CN101611143A Methods and devices for the delivery of peptides into the gastric mucosa
12/23/2009	CN101611052A Multimeric FC receptor polypeptides including a modified FC domain
12/23/2009	CN101611035A Pyrazolopyrimidine compound
12/23/2009	CN101611033A Indole derivatives as S1P1 receptor agonists
12/23/2009	CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
12/23/2009	CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative
12/23/2009	CN101607984A Multi-copy polypeptide and application thereof
12/23/2009	CN101607073A Method for cultivating Chinese medicinal health care product ganoderma and health preservation liquid thereof by conventional biotechnology
12/23/2009	CN101607028A Dermatologic medicine prepared from wartwort plant
12/23/2009	CN101607020A Medicament for curing urticaria
12/23/2009	CN101606987A Chinese veterinary medicament for preventing and treating animal viral disease
12/23/2009	CN101606983A Method for curing cold by soaking feet in traditional Chinese medical liquid
12/23/2009	CN101606971A Preparation method of Baikal skullcap root extract of bulk drug for livestock
12/23/2009	CN101606964A Veterinary traditional Chinese medical compound preparation
12/23/2009	CN101606963A Traditional Chinese medicine combination for enhancing disintoxication and improving dyscrasia of cancer patients
12/23/2009	CN101606930A Pseudolaric acid B and application of derivative thereof in preparation of immunity inhibitor
12/23/2009	CN101606692A Natural colour viscera-nourishing nutritional porridge and preparation method
12/23/2009	CN100572397C Method for preparing lilium brownii polysaccharide for reinforcing phylactic power
12/23/2009	CN100571765C Chinese-medicinal decoction for treating hives
12/23/2009	CN100571536C Wild mineral mung bean powder preparation and mung bean orange juice and its processing method
12/23/2009	CN100571525C Bamboo charcoal bag health-care tea
12/23/2009	CA2728514A1 Paediatric compositions for treating multiple sclerosis
12/23/2009	CA2728276A1 Combination therapies against cancer
12/23/2009	CA2728060A1 Modified beta-lactoglobulins for immunotherapy of milk allergy
12/23/2009	CA2727911A1 Phenyl-alkyl piperazines having a modulating activity of tnf
12/23/2009	CA2725481A1 Nicotinamide derivatives
12/23/2009	CA2724998A1 Nicotinamide derivatives
12/23/2009	CA2724767A1 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
12/22/2009	US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator
12/22/2009	US7635693 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
12/22/2009	US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/22/2009	US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009	US7635556 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
12/22/2009	US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy
12/22/2009	US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
12/22/2009	US7635464 Selective targeting of apoptotic cells
12/22/2009	CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
12/22/2009	CA2447166C Delivery of erectile dysfunction drugs through an inhalation route
12/22/2009	CA2446990C Delivery of sedative-hypnotics through an inhalation route
12/22/2009	CA2446917C Delivery of antipsychotics through an inhalation route
12/22/2009	CA2446916C Delivery of opioids through an inhalation route
12/22/2009	CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009	CA2415214C Phosphotetrahydropyran compounds
12/22/2009	CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same
12/22/2009	CA2405593C Macrolides
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/22/2009	CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/22/2009	CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009	CA2337571C Antihistamine leukotriene combinations
12/22/2009	CA2307879C Treatment of t-helper cell type 2 mediated immune diseases
12/17/2009	WO2009152072A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents
12/17/2009	WO2009151626A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
12/17/2009	WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
12/17/2009	WO2009151496A2 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
12/17/2009	WO2009151331A1 Immune system stimulating nutrition
12/17/2009	WO2009151329A1 Nutrition for prevention of infections
12/17/2009	WO2009150888A1 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent
12/17/2009	WO2009150371A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
12/17/2009	WO2009150310A1 Use of the pat nonapeptide in the treatment of autoimmune diseases
12/17/2009	WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof
12/17/2009	WO2009150101A1 Pharmaceutical compositions comprising n-[2-((2r)-2-{[4-[(4-chlorophenyl)methyl]-l-oxo-2(ih)-phthalaz inyl]methyl}-l- pyrrolidinyl)ethyl]-4-(methyloxy)butanamide
12/17/2009	WO2009149539A1 Enhancing antigen-specific cd8+ t cell response using irf-7 mrna
12/17/2009	WO2009149508A1 Novel potassium channel blockers and uses thereof
12/17/2009	WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors
12/17/2009	WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections
12/17/2009	WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis
12/17/2009	WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis
12/17/2009	WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis
12/17/2009	WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection
12/17/2009	WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
12/17/2009	WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection
12/17/2009	WO2009033796A8 Use of a peptide as a therapeutic agent
12/17/2009	WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections
12/17/2009	WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312386 Novel crystals of substituted phenylalkanoic acid and method of producing the same
12/17/2009	US20090312385 Cannabinoid receptor modulators for treating non-immediate type allergic diseases
12/17/2009	US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/17/2009	US20090312334 Immunomodulating Heterocyclic Compounds
12/17/2009	US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors
12/17/2009	US20090312319 Certain chemical entities, compositions and methods
12/17/2009	US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009	US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/17/2009	US20090311288 Imidazoquinoxaline compounds as immunomodulators
12/17/2009	US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine
12/17/2009	US20090311276 Nanolipoprotein particles and related compositions, methods and systems
12/17/2009	US20090311268 Cd40-binding activating antibodies
12/17/2009	US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009	US20090311241 Human antibodies that bind human IL-12 and methods for producing
12/17/2009	US20090311229 Isolation and Identification of Cross-Reactive T Cells
12/17/2009	US20090311218 Novel mutant interferon-alpha protein, particularly interferon-alpha subtype alpha 8; provides agents for susceptive diseases superior in anti-viral and anti-tumor actions compared with conventional agents for susceptive diseases; agents against tumors, viral diseases, and infection diseases
12/17/2009	US20090311216 Recombinant interferon-beta with enhanced biological activity

1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1172